Clostridium is the primary obligate anaerobe investigated as an anticancer agent. In the last decade, there has been significant progress in the development and refinement of strategies based on tumor colonization using a range of Clostridium species. Based on our extensive experience, Creative Biolabs provides Clostridium acetobutylicum based drug development for our customers all over the world. clostridia probiotic
https://live-biotherapeutic.creative-biolabs.com/clostridium-acetobutylicum.htm
